Publisher
Springer Science and Business Media LLC
Subject
Management of Technology and Innovation,Health Policy,Issues, ethics and legal aspects,Health(social science)
Reference37 articles.
1. Baltimore, D., Berg, P., Botchan, M., et al. (2015). Biotechnology. A prudent path forward for genomic engineering and germline gene modification. Science,348, 36–38.
2. Bosley, K. S., Botchan, M., Bredenoord, A. L., et al. (2015). CRISPR germline engineering-the community speaks. Nature Biotechnology,33, 478–486.
3. Carlson-Stevermer, J., Goedland, M., Steyer, B., Movaghar, A., Lou, M., Kohlenberg, L., et al. (2016). High-Content Analysis of CRISPR-Cas9 Gene-Edited Human Embryonic Stem Cells. Stem Cell Reports,6, 109–120.
4. Collins, F. (2015). Statement on NIH funding of research using gene-editing technologies in human embryos. The NIH Director—National Institutes of Health (NIH). https://www.nih.gov/about-nih/who-we-are/nih- director/statements/statement-nih-funding-research-using-gene-editing-technologies-human-embryos. Retrieved February 25, 2019.
5. Dajani, R. (2014). Jordan’s stem-cell law can guide the Middle East. Nature,510, 189.
Cited by
7 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献